FDA

News

Lilly pauses COVID-19 antibody trial after factory hits trou...

Eli Lilly has put a clinical trial of its COVID-19 antibody therapy on hold after FDA inspectors found serious quality control problems at the plant, according to press reports.

News

FDA gives COVID-19 vaccine ‘advice’ after White House blocks...

The FDA may have been blocked from issuing stricter guidelines for emergency approval of COVID-19 vaccines by the Trump administration, but it has still managed to make its new approach pub

News

CTI wins over FDA to claim early review of myelofibrosis dru...

Shares in US biotech CTI BioPharma have shot up after the FDA agreed to an accelerated review early next year of its lead drug pacritinib for low blood platelets (thrombocytopenia) caused b

News

EMA review of AZ’s COVID-19 vaccine imminent; report

The EU regulator is poised to start a review of AstraZeneca and Oxford University’s COVID-19 vaccine, but the FDA is widening its investigation into the shot’s safety, according to reports

News

FDA fast-tracks AbbVie's spinal injury drug

The FDA has fast tracked development of AbbVie’s potential spinal injury drug, elezanumab, a process that will be aided by digital analysis.

News

FDA slams brakes on Inovio's final-stage COVID-19 vaccine tr...

Inovio Pharma’s plan to start pivotal testing of its COVID-19 vaccine has been delayed by FDA requests for more information, sending its shares into a swift decline.

Lilly pauses COVID-19 antibody trial after factory hits trou...

FDA gives COVID-19 vaccine ‘advice’ after White House blocks...

CTI wins over FDA to claim early review of myelofibrosis dru...

EMA review of AZ’s COVID-19 vaccine imminent; report

FDA fast-tracks AbbVie's spinal injury drug

FDA slams brakes on Inovio's final-stage COVID-19 vaccine tr...

Argenx pens $2.2bn deal to buy autoimmune biotech Forte

Discover a new era of healthcare panel engagement: Grounded ...

FDA

Editor's Picks